Liminatus Pharma, Inc. LIMN
2.94 USD +0.17 (+6.14%)
At closeNov 11, 2026, 6:53 PM EST
2.92 -0.02 -0.71%
After hours · Nov 11, 6:53 PM ET
2.85 Day range 3.08
2.40 52-week range 141.50
- YTD
- -90.36%
- 1 year
- -94.95%
- Market cap
- 3.95M
- EPS (ttm)
- -24.41
- YTD return
- -90.36%
- 1-year return
- -94.95%
- Volume
- 27.22K
- Avg volume
- 212.70K
- Open
- 2.98
- Previous close
- 2.77
- Day's range
- 2.85 – 3.08
- 52-week range
- 2.40 – 141.50
No chart data for this range yet.
Financials — quick view
LIMN Revenue — quarterly 0
LIMN Net income — quarterly -1.41M
LIMN EPS — quarterly -1.50
News
12 Health Care Stocks Moving In Friday's Pre-Market Session 
Liminatus Pharma Regains Compliance With Nasdaq’s Minimum Bid Price Rule 
Liminatus Pharma Regains Compliance with Nasdaq Minimum Bid Price Rule - 12 Health Care Stocks Moving In Wednesday's After-Market Session
Liminatus Pharma Engages Synex Consulting To Support Clinical Development Of IBC101, CD19xCD22 Bivalent CAR-T Cell Therapy Candidate 
Liminatus Pharma Engages Synex as Contract Research Organization to Support Phase 1/2a Clinical Development of CD19xCD22 bivalent CAR-T therapy - 12 Health Care Stocks Moving In Tuesday's After-Market Session
Liminatus Pharma Board Adopts Resolutions Approving Reverse Stock Split Of Its Common Stock At Ratio Of 1-For-50 
Liminatus Pharma, Inc. Announces Reverse Stock Split of its Common Stock - 12 Health Care Stocks Moving In Thursday's Intraday Session
Your note
Sign in to keep a note on LIMN — it syncs with the Stock Master app.